Studien | Der Arzneimittelbrief

ARTISTIC

ARTesunate in Combination With Standard-Of-Care T-DM1 as Second-Line Treatment in Patients With Advanced HER2-Positive Breast Cancer Progressing on Trastuzumab-Pertuzumab Chemotherapy

ARTORIA-R

PAtients pResenTing with cOngenital heaRt dIseAse Register

ARTPER

Peripheral Arterial disease study

ARTS

Arterial Revascularization Therapies Study

ARTS II

Arterial Revascularization Therapies Study II

ARTS-DN

MinerAlocorticoid Receptor antagonist Tolerability Study-Diabetic Nephropathy

ARTS-HF

MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure

ARTSS

Argatroban Stroke Treatment - A Pilot Safety Study

ARTSS-2

Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke

ARTSS-IA

Safety and feasibility of Argatroban, Recombinant Tissue plasminogen activator and intra-arterial Therapy in Stroke

ARUBA

A Randomized Trial of Unruptured Arteriovenous Malformations

ARVD/C

North American ARrhythmogenic right Ventricular Dysplasia study

ARYA

Atherosclerosis Risk in Young Adults study

AS

Angioplasty or Stent

ASA-STAT

Aspirin and Simvastatin for pulmonary arterial hypertension

ASAAC

AcetylSAlycylic Acid versus Coumarin study

ASAMET

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients

ASAP

Acetyl Salicylic Acid Persantine study

ASAP

Acupuncture in Patients With Stable Angina Pectoris

ASAP

Acute Stroke Accurate Prediction study

ASAP

Adverse drug reaction Signals Analysis Project

ASAP

Antioxidant Supplementation in Atherosclerosis Prevention

ASAP

ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology

ASAP

Australian Surgical Antibiotic Prophylaxis

ASAP

Azimilide Supraventricular Arrhythmia Program

ASAP

Effect of Atorvastatin versus Simvastatin on Atherosclerosis Progression study

ASAP-TOO

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

ASAS-COMOSPA

Assessment of SpondyloArthritis international Society COMOrbidities in SpondyloArthritis

ASAS-PerSpA

Assessment of SpondyloArthritis international Society Peripheral involvement in SpondyloArthritis study

ASC4FIRST

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

ASCB

ASymptomatic Cervical Bruit study

ASCEMBL

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

ASCEND

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

ASCEND

A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

ASCEND

A Study of Cardiovascular Events iN Diabetes

ASCEND

Assessing Social and Community Environments with National Data for Veteran Suicide Prevention Study

ASCEND

Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

ASCEND PLUS

A research study to test whether a treatment called oral semaglutide can protect people with type 2 diabetes from heart attacks, strokes, and other health problems

ASCEND-03

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

ASCEND-1

A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase

ASCEND-10

An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies

ASCEND-2

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

ASCEND-3

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

ASCEND-4

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer-4

ASCEND-5

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer-5

ASCEND-7

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges

ASCEND-8

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer-8

ASCEND-9

LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib

ASCEND-D

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis

ASCEND-HF

Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure

ASCEND-ID

Anemia Studies in Chronic kidney disease (CKD): Erythropoiesis via a Novel prolyl hydroxylase inhibitor (PHI) Daprodustat-in Incident Dialysis

ASCEND-ND

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis

ASCEND-NHQ

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life

ASCEND-TD

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis

ASCENDE-SBRT

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

ASCENT

A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer

ASCENT

ACS Stent Clinical Equivalence in de Novo lesions Trial

ASCENT

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

ASCENT

Altitude Sickness in Climbers and Efficacy of NSAIDs Trial

ASCENT

Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer Triple-Negative Breast Cancer